Patheon sees faster revenue growth
Article Abstract:
Pharmaceutical company Pantheon Inc of Mississauga, Ontario, has posted a profit of C$4 million, or 12 cents per share, on revenue of C$70.5 million in the FY ended Oct 31, 1998. The company is projecting revenue of more than C$100 million for the current fiscal year as result of its expanded capacity. Pantheon, which is acquiring 300,000-sq-ft pharmaceutical plant in Buffallo, NY, from Bristol-Myers-Squibb Co., operates five plants in Ontario and one in Italy.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
Biovail's 'quarter of note' stronger than expected
Article Abstract:
The details on Biovail Corp., which posted better second quarter financial results, are examined.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Canada seen leading G7 growth. Rebound seen across the country. Blackout seen hitting economy
- Abstracts: Aluminum firms trying to rescue merger. Alcan's bigger bid rejected
- Abstracts: First Marathon seeks electronic muscle. Waterhouse profit plunges 90% in quarter
- Abstracts: Geac buying software assets from U.S. firm. Roxio set to relaunch Napster by end of year
- Abstracts: Nestle close to buying Ralston. SEC alleges insider trading in Nestle deal